Medical Device Cybersecurity Services in Sweden
As medical devices become increasingly connected, cybersecurity has emerged as a critical factor in regulatory approval and patient safety. For manufacturers in Sweden targeting the U.S. market, FDA 510(k) submissions now require strong cybersecurity evidence, particularly through Vulnerability Assessment (VA) and Penetration Testing (PT).
Cyberintelsys delivers FDA-aligned medical device cybersecurity testing services that help Swedish manufacturers demonstrate robust risk management, secure design, and regulatory readiness.
Understanding FDA 510(k) Cybersecurity Requirements
The U.S. FDA emphasizes a secure-by-design approach for medical devices, especially those involving software, wireless connectivity, cloud integration, or data exchange. Cybersecurity is evaluated as part of device safety and effectiveness during the 510(k) review process.
Key FDA cybersecurity expectations include:
Identification of cybersecurity threats and vulnerabilities
Risk-based vulnerability management
Verification and validation of security controls
Evidence of penetration testing and security testing
Documentation aligned with premarket cybersecurity guidance
Why Vulnerability Assessment & Penetration Testing Are Essential for 510(k)
Vulnerability Assessment and Penetration Testing play a vital role in proving that your medical device can withstand real-world cyber threats without compromising patient safety.
Vulnerability Assessment (VA)
A structured process to identify known and emerging security weaknesses across:
Device firmware and software
Operating systems and libraries
Communication interfaces (Bluetooth, Wi-Fi, USB)
APIs, cloud platforms, and backend systems
Penetration Testing (PT)
An attacker-simulated exercise that validates whether vulnerabilities can be exploited to:
Alter device functionality
Access sensitive patient data
Interrupt clinical workflows
Compromise system integrity
Together, VA/PT provides FDA-acceptable evidence of proactive cybersecurity risk mitigation.
FDA-Aligned VA/PT Methodology by Cyberintelsys
Cyberintelsys applies a risk-based, FDA-ready cybersecurity testing approach customized for medical devices developed in Sweden.
1. Device Architecture & Threat Scoping
Device classification and intended use analysis
Identification of attack surfaces
Mapping of software and hardware components
2. Vulnerability Identification
Static and dynamic code analysis
Firmware and protocol testing
Dependency and third-party component review
CVE and SBOM-based vulnerability mapping
3. Controlled Penetration Testing
Network and wireless attack simulations
Authentication and authorization testing
Privilege escalation attempts
Data integrity and availability testing
4. Risk Scoring & Impact Analysis
FDA-aligned risk prioritization
Patient safety and clinical impact evaluation
Likelihood vs severity assessment
5. Remediation & Retesting Support
Actionable remediation guidance
Security improvement recommendations
Validation retesting for closure evidence
Cybersecurity Documentation for FDA 510(k) Submission
Cyberintelsys delivers submission-ready documentation tailored for FDA review, including:
Vulnerability Assessment Report
Penetration Testing Summary
Risk analysis and mitigation mapping
Cybersecurity verification & validation evidence
Secure design and defense-in-depth justification
These reports align with FDA premarket cybersecurity guidance and support a smoother 510(k) clearance process.
Supporting Swedish Medical Device Manufacturers
Sweden is a global leader in medical technology innovation, and exporting to the U.S. requires strict compliance with FDA cybersecurity expectations. Cyberintelsys supports:
MedTech startups and established manufacturers
Software as a Medical Device (SaMD)
Connected and implantable medical devices
Remote monitoring and digital health platforms
Our services integrate seamlessly with ISO 13485, ISO 14971, and IEC 62304 processes commonly adopted by Swedish manufacturers.
Benefits of Choosing Cyberintelsys for FDA 510(k) VA/PT
FDA-focused cybersecurity testing expertise
Deep experience in medical device security
Risk-based approach aligned with patient safety
Clear, regulator-friendly documentation
End-to-end support from testing to submission readiness
Future-Proofing Medical Device Cybersecurity
Beyond FDA clearance, ongoing vulnerability management is essential to maintain device safety throughout its lifecycle. Cyberintelsys helps manufacturers implement:
Post-market cybersecurity monitoring
Secure update and patch management strategies
Long-term vulnerability disclosure readiness
Conclusion
For Swedish medical device manufacturers pursuing FDA 510(k) clearance, Vulnerability Assessment and Penetration Testing are no longer optional—they are essential. With Cyberintelsys as your cybersecurity partner, you gain regulatory confidence, reduced approval risks, and enhanced patient safety.
By addressing cybersecurity proactively, you not only meet FDA expectations but also build resilient, trusted medical technologies for the global market.